These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27268117)

  • 1. CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals.
    Bialvaei AZ; Kafil HS; Asgharzadeh M; Aghazadeh M; Yousefi M
    Braz J Microbiol; 2016; 47(3):706-11. PubMed ID: 27268117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.
    Munday CJ; Whitehead GM; Todd NJ; Campbell M; Hawkey PM
    J Antimicrob Chemother; 2004 Sep; 54(3):628-33. PubMed ID: 15294889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
    Pitout JD; Hossain A; Hanson ND
    J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
    Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Enterobacteriaceae isolates obtained from a tertiary care hospital in Mexico, which produces extended-spectrum β-lactamase.
    Morfín-Otero R; Mendoza-Olazarán S; Silva-Sánchez J; Rodríguez-Noriega E; Laca-Díaz J; Tinoco-Carrillo P; Petersen L; López P; Reyna-Flores F; Alcantar-Curiel D; Garza-Ramos U; Garza-González E
    Microb Drug Resist; 2013 Oct; 19(5):378-83. PubMed ID: 23725513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988)].
    Ben Hassen A; Fournier G; Kechrid A; Fendri C; Ben Redjeb S; Philippon A
    Pathol Biol (Paris); 1990 May; 38(5):464-9. PubMed ID: 2195457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
    Bayraktar B; Toksoy B; Bulut E
    Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
    Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
    J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Perils of Extended Spectrum
    Parajuli NP; Maharjan P; Joshi G; Khanal PR
    Biomed Res Int; 2016; 2016():1782835. PubMed ID: 28119921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.